初次型非骨水泥股骨柄用于翻修全髋关节置换术的结局
本研究基于注册数据库回顾2010至2020年使用初次型干骺端固定股骨柄行翻修全髋关节置换术的患者,排除既往翻修、骨水泥或植骨增强及随访不足2年者,最终纳入78例,平均随访5.2年。无菌性股骨柄生存率为94%,16.5%需再翻修,无因无菌性松动行股骨翻修。
要点
- 初次型干骺端固定股骨柄用于翻修全髋关节置换术,无菌性股骨柄生存率为94%。
- 13例(16.5%)需再翻修,其中5例假体周围骨折、6例不稳、2例复发感染。
- 无因无菌性松动行股骨翻修,3例骨折需柄再翻修。
核心结论
- 对于近端干骺端骨量保留的患者,初次型干骺端固定股骨柄在翻修全髋关节置换术中提供可靠固定,并发症率与既往文献报道的翻修全髋关节置换术相似。
研究设计与样本
- 回顾性注册数据库研究,纳入2010至2020年因任何原因行翻修全髋关节置换术并使用初次型干骺端固定股骨柄行股骨重建的患者,排除既往翻修史、使用骨水泥或植骨增强者及缺乏2年随访的7例,最终78例符合标准,平均随访5.2年(范围2.0至10.0年)。
主要发现
- 翻修指征最常见为无菌性松动(44%)或感染(34%)。
- 翻修前Paprosky股骨分型:I型41例(52%),II型37例(47%),IIIA型1例(1%)。
- 13例(16.5%)需再翻修,其中5例假体周围骨折、6例不稳、2例复发感染;13例中7例需股骨部件翻修。
- 排除复发感染后,队列无菌性股骨部件生存率为94%。
- 3例发生骨折需柄再翻修:1例Vancouver B1骨折发生于术后>2年,2例Vancouver B2骨折发生于术后6个月内;无因无菌性松动行股骨翻修。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An abundance of literature exists assessing outcomes of revision total hip arthroplasty (THA) using diaphyseal-engaging stems; however, there is little research into the use of primary-style femoral stems in revision THA. Primary stems may have benefits, including cost reduction, maintenance of proximal bone stock, and ease of potential future reconstructions. The purpose of this study was to evaluate the aseptic survival rate of revision THAs using primary femoral stems. METHODS: A review of our registry was performed to identify patients from 2010 to 2020 who underwent all-cause revision THA utilizing a primary metaphyseal-engaging stem for femoral reconstruction. Patients who had a history of previous revision THA or those treated with cement or bone graft augmentation were excluded. There were seven patients excluded due to a lack of 2-year follow-up. Implant survival, complications requiring revision surgery, and ambulatory status at final follow-up were documented. There were 78 patients who met the final inclusion criteria. The mean follow-up was 5.2 years (range, 2.0 to 10.0). RESULTS: The most common indications for index revision were aseptic loosening (44%) or infection (34%). Prerevision Paprosky classification of the femur was Type I in 41 patients (52%), Type II in 37 patients (47%), and Type IIIA in one patient (1%). Overall, 13 patients (16.5%) required rerevision, five for periprosthetic fracture, six for instability, and two for recurrent infection. Of those, seven of 13 required femoral component revision. When excluding recurrent infections, the aseptic femoral component survivorship for the cohort was 94%. There were three patients who sustained a fracture requiring stem rerevision. A Vancouver B1 fracture was sustained > 2 years postoperatively, and two Vancouver B2 fractures were sustained within 6 months postoperatively. There were no femoral rerevisions for aseptic loosening. CONCLUSIONS: Primary metaphyseal-engaging femoral stems provide reliable fixation during revision THA in patients who have preserved proximal metaphyseal bone, with similar complication rates to those previously reported in the literature for revision THA.
引用
- Dombrowsky AR, Jolissaint JE, Avercamp BJ, et al. Outcomes of Primary Cementless Femoral Stems Used in Revision Hip Arthroplasty. J Arthroplasty. 2025. PMID: 40373833. doi:10.1016/j.arth.2025.05.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。